Skip to main content
. 2021 Feb 24;15:431–442. doi: 10.2147/PPA.S286935

Table 3.

Patient Recall of Medication Guide, Patient Counseling Document, and Specific Counseling Topics

Total Number of Respondents Commercial Medicare Advantage Medicaid
N (%) N (%) N (%)
382 (100) 43 (100) 40 (100)
Received and/or read MG (Yes); N (%) 375 (98) 43 (100) 38 (95)
Received MG from pharmacist with last ER/LA opioid analgesic prescription fill (Yes); N (%) 356 (93) 39 (91) 32 (80)
Received MG from pharmacist in the last 12 months (Yes); N (%) 360 (94) 40 (93) 32 (80)
Received MG from any source besides pharmacist in the last 12 months (Yes); N (%) 38 (10) 4 (9) 11 (28)
Read MG; N (%)
 Read all, with each pharmacy fill 86 (23) 11 (26) 5 (13)
 Read all, at least once 214 (56) 20 (47) 19 (48)
 Read some, at least once 73 (19) 11 (26) 16 (40)
 Never read MG 9 (2) 1 (2) 0 (0)
Usefulness of the information in the MG; N (%)
 Very useful 246 (64) 32 (74) 14 (35)
 Somewhat useful 115 (30) 6 (14) 19 (48)
 Not very useful/Not useful at all 13 (3) 5 (12) 7 (18)
 Refused 3 (1) 0 (0) 0 (0)
Understood all/most information in the MG; N (%) 358 (94) 36 (83) 31 (78)
Received and/or healthcare provider referenced PCD (Yes); N (%) 180 (47) 28 (65) 21 (53)
Received PCD from healthcare provider when first prescribed current ER/LA opioid analgesic (Yes); N (%) 143 (79) 20 (71) 17 (81)
Healthcare provider referred to or discussed PCD when prescribing the current ER/LA opioid analgesic in the last 12 months (Yes); N (%) 103 (57) 14 (50) 16 (76)
Healthcare provider completed a Patient Prescriber Agreement (PPA) or patient contract when the current ER/LA opioid analgesic was prescribed in the last 12 months (Yes); N (%) 116 (64) 18 (64) 18 (86)
Frequency healthcare provider did following activities in the past 12 months when visited (Always or Regularly); N (%)
 a. Used the PCD on ER/LA opioids for discussions. 140 (37) 21 (49) 18 (45)
 b. Cautioned about important risks associated with ER/LA opioid analgesics, including overdose or taking or using too much. 259 (68) 33 (77) 26 (65)
 c. Discussed how to safely discontinue ER/LA opioid analgesics if they are no longer needed. 192 (50) 21 (49) 27 (68)
 d. Counseled on the most common side effects from using ER/LA opioid analgesics. 260 (68) 28 (65) 27 (68)
 e. Instructed about the importance and how to safely dispose of any unused ER/LA opioid analgesics. 175 (46) 24 (56) 24 (60)
 f. Instructed about keeping ER/LA opioid analgesics safe and away from children. 250 (65) 32 (74) 25 (63)
 g. Instructed not to share ER/LA opioid analgesics with anyone else. 242 (63) 29 (67) 26 (65)
 h. Asked about medical history when prescribing ER/LA opioid analgesics. 300 (79) 28 (65) 35 (88)
 i. Talked about how much medication to take or use when ER/LA opioid analgesics were prescribed. 327 (86) 35 (81) 35 (88)
 j. Talked about what to do with extra medication when ER/LA opioid analgesics were prescribed. 180 (47) 22 (51) 23 (58)

Note: Percentages may not sum to 100% due to rounding.

Abbreviations: MG, medication guide; ER/LA, extended-release/long-acting; KAS, knowledge assessment score; PCD, patient counseling document; SD, standard deviation; N, number.